the market?
Neurocrine Biosciences, Inc.
NASDAQ: NBIX
12.01
-0.05
(-0.41%)
| Today's Open | $12.06 |
|---|---|
| Previous Close | $12.06 |
| Daily Range | $11.91 - $12.53 |
| 52-Week Range | $6.25 - $12.85 |
| Market Cap | $801.5M |
| P/E Ratio | -134.00 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 434,893 |
| Average Daily Volume | 562,629 |
| Current FY EPS | -$0.80 |
How do you think NBIX
will perform against the market?
Top NBIX Bull/Bear Pitches
bhessel (< 20)
Submitted
December 27, 2007
22 May 07 As with Élan—one of our other biotechs—Neurocrine Biosciences (NBIX) have had their ups and downs. The stock was at an all-time high $70 14 months ago when the FDA somewhat surprizingly tur … More
TMFUltraLong (< 20)
Submitted
June 22, 2010
Neurocrine Biosciences, how you are still an operational entity is beyond my comprehension. NBIX has signed two deals over the last two days, with Abbott and a smaller deal with Boehringer to supply t … More
News & Commentary
3 Stocks Near 52-Week Highs Worth Selling
Are these stocks sells or belles? You be the judge!3 Humongous Health-Care Stocks This Week
Some of the sector's big movers.The Most Promising Dividends in Pharmaceutical Companies
Here are some hefty payouts, and some are growing briskly.2-Star Stocks Poised to Plunge: Neurocrine Biosciences?
Market-lagging returns could be written in these stars.The Week's Biggest Stock Laggards
The market lost some ground this week, and some stocks took serious plunges.This Week's 5 Dumbest Stock Moves
Don't let stupid happen to you.Neurocrine Biosciences Shares Plunged: What You Need to Know
Is this meaningful or just another movement?Sector
Healthcare
Industry
Drugs
Neurocrine Biosciences, Inc. (NBIX) Description
Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/
